Raphael, G., Taveras, H., Iverson, H., O’Brien, C., & Miller, D. (2016). Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma. Taylor & Francis.
Chicago Style CitationRaphael, Gordon, Herminia Taveras, Harald Iverson, Christopher O’Brien, and David Miller. Twelve- and 52-week Safety of Albuterol Multidose Dry Powder Inhaler in Patients With Persistent Asthma. Taylor & Francis, 2016.
MLA CitationRaphael, Gordon, et al. Twelve- and 52-week Safety of Albuterol Multidose Dry Powder Inhaler in Patients With Persistent Asthma. Taylor & Francis, 2016.
Warning: These citations may not always be 100% accurate.